As of 11 January 2016
20th January 2016
Theme: Turning points of care in liver diseases
Wednesday, 20 January 2016 | ||
9.00-10.15 | Viral hepatitis Moderators: Tawesak Tanwandee, Satawat Thongsawat |
|
9.00-9.25 | Current and future management of CHB Seng Gee Lim, Singapore |
|
9.25-9.50 | Today treatment of CHC – which drug and how? Teerha Piratvisuth, Thailand |
|
9.50-10.15 | Liver transplant for HCV K.Rajender Reddy, USA |
|
10.15-10.30 | Coffee break | |
10.30-12.00 | Metabolic liver disorders Moderators: Teerha Piratvisuth, Chinnavat Sutthivana |
|
10.30-10.55 | Alcoholic hepatitis: steroid, pentoxifylline or liver transplantation Diana Alcantara-Payawal, Philippines |
|
10.55-11.20 | NASH in Asia-Pacific: what’s new? Jacob George, Australia |
|
11.20-11.45 | Non-invasive assessment of fat and fibrosis Vincent Wong, Hong Kong |
|
11.45-12.00 | Q&A | |
12.00-13.30 | Lunch Symposium I Bristol-Myers Squibb Company “New breakthrough brings effective Hepatitis C Cure“ Moderator: Tawesak Tanwandee Speakers: Teerha Piratvisuth, Anuchit Chutaputti |
|
13.30-14.45 | New strategy in the management of decompensate cirrhosis Moderators: Anuchit Chuttaputti, Wattana Sukeepaisarnjaroen |
|
13.30-13.55 | Natural course and prognostic stratification of cirrhosis Abhasnee Sobhonslidsuk, Thailand |
|
13.55-14.20 | Evidence-base management of esophageal and gastric varices Rino Alvani Gani, Indonesia |
|
14.20-14.45 | Refractory ascites and hyponatremia Siwaporn Chainuvati, Thailand |
|
14.45-15.00 | Coffee break | |
15.00-16.30 | Changing trends in the management of hepatocellular carcinoma Moderators: Pisaln Mairiang, Apinya Leerapun |
|
15.00-15.25 | How to reduce the risk of HCC? Rosmawati Mohamed, Malaysia |
|
15.25-15.50 | Current trend in the management of HCC Grace Wong, Hong Kong |
|
15.50-16.15 | Liver transplant for HCC Yongyut Sirivatanauksorn, Thailand |
|
16.15-16.30 | Q&A | |
17.00-18.30 | APLD-KASL Joint Meeting | |
17.00-17.15 | The current status of liver disease in Korea Moderator: Kwang-Hyub Han, Korea Speaker: Sang Hoon Ahn, Korea |
|
17.15-17.30 | Clinical implication of hemodynamic alterations in cirrhosis Moderator: Kwang-Hyub Han, Korea Speaker: Soon Koo Baik, Korea |
|
17.30-17.45 | Performance of alpha-fetoprotein deteriorates by antiviral therapy in the surveillance for hepatitis B virus-related hepatocellular carcinoma Moderator: Seung Kew Yoon, Korea Speaker: Jin Wook Kim, Korea |
|
17.45-18.00 | Transient elastography into the the current prediction models of HCC Moderator: Seung Kew Yoon, Korea Speaker: Do Young Kim, Korea |
|
18.00-18.30 | Case-based study Panelist: Sang Hoon Ahn, Korea Soon Koo Baik, Korea Jin Wook Kim, Korea Do Young Kim, Korea Case presenter: Pimsiri Sripongpun, Thailand |
21st January 2016
Theme: New paradigms in the management of liver diseases
Thursday, 21st January 2016 | |
8.30-9.00 | Plenary I Screening of viral hepatitis and HCC: the Why and the How? Moderator: Anuchit Chutaputti, Thailand Speaker: Ray Kim, USA |
9.00-9.30 | Presidential lecture Novel Endpoints of HBV therapy in the 21stCentury Moderators: Seng Gee Lim, Singapore Satawat, Thongsawat, Thailand Speaker: Tawesak Tanwandee, Thailand |
9.30-9.50 | Opening Ceremony |
9.50-10.20 | Chainuvati Lecture Pharmacologic management of NASH: Towards a new paradigm Moderator: Tawesak Tanwandee, Thailand Speaker: Leon Adams, Australia |
10.20-10.50 | Coffee break |
10.50-12.00 | Symposium I New paradigms in NAFLD: Moderators: Sombat Treeprasertsuk, Thailand Jacob George, Australia |
10.50-11.10 | 1.Diets and vitamins for NAFLD, what’s known and what’s new Leon Adams, Australia |
11.10-11.30 | 2.”Good Bugs and Bad Bugs… Gut microbiota in NAFLD” Phunchai Charatcharoenwitthaya, Thailand |
11.30-11.50 | 3.HCC in the non-cirrhotic NASH patient, who gets it and can we prevent it? Vincent Wong, Hong Kong |
11.50-12.00 | Discussion |
12.00-13.30 | Lunch Symposium II MSD (Thailand) Ltd. |
13.30-17.30 | APLD-AASLD Joint Meeting Asian and American perspectives on the management of viral hepatitis C |
13.30-14.40 | Symposium II Hepatitis C: Who to treat and with what Moderators: Panida Thong-u-thaisri, Thailand Rino Alvani Gani, Indonesia |
13.30-13.50 | 1.What AASLD-IDSA guidance says Ray Kim, USA |
13.50-14.10 | 2.Guidance versus real life practice in the US K.Rajender Reddy, USA |
14.10-14.30 | 3.ASEAN perspective Teerha Piratvisuth, Thailand |
14.30-14.40 | Discussion |
14.40-15.00 | Coffee break |
15.00-16.30 | Symposium III Hepatitis C in special populations Moderators: Piyawat Komolmit, Thailand President of Ho Chi Minh City Association for the Study of Liver Diseases |
15.00-15.20 | Modern treatment of HCV-HIV coinfection Chutima Pramoolsinsap, Thailand |
15.20-15.40 | Hepatitis C and transplantation: is it time to change our thinking? K.Rajender Reddy, USA |
15.40-16.00 | HCV and renal disease Ray Kim, USA |
16.00-16.20 | Management of HCV patients with hemoglobinopathies Lai Wei, China |
16.20-16.30 | Discussion |
16.30-17.30 | Case-based study: practical practice in the management of HCV in Asia Moderator: Jacob George, Australia Panelist: Manuel Romero-Gómez, Spain K.Rajender Reddy, USA Seng Gee Lim, Singapore Lai Wei, China Case presenters: Naichaya Chamroonkul, Thailand Apinya Leerapun, Thailand Watcharasak Chotiyaputta, Thailand |
17.30-18.00 | Welcome reception |
19.00-21.00 | Faculty Dinner (By invitation only) |
22nd January 2016
Theme: New paradigms in the management of liver diseases
Friday, 22nd January 2016 | |
8.30-16.30 | APLD-Italian Joint Symposium Asian and Mediterranean perspectives in the management of HBV infection |
8.30-9.10 | Plenary II Hepatitis B Guidelines over the decades Moderators: Pisit Tangkijvanich, Thailand Ferruccio Bonino, Italy |
8.30-8.45 | 1.Asian perspective Satawat Thongsawat, Thailand |
8.45-9.00 | 2.Western perspective Ferruccio Bonino, Italy |
9.00-9.10 | Discussion |
9.10-10.20 | Symposium IV New paradigms in the management of HBV: Moderators: Teerha Piratvisuth, Thailand Rosmawati Mohamed, Malaysia |
9.10-9.30 | 1. Combination & Switch Therapies Henry LY Chan, Hong Kong |
9.30-9.50 | 2. Long Term & Stopping role in the management of NUC Therapy Seng Gee Lim, Singapore |
9.50-10.10 | 3. Dashboard for personalized management of chronic HBsAg carriers and CHB Maurizia Brunetto, Italy |
10.10-10.20 | Discussion |
10.20-10.50 | Coffee break |
10.50-12.00 | Meet the experts (70 min) Hepatitis B Clinical Practice: Difficult to treat Cases (discussion of 3-4 real cases) Moderators: Chutima Pramoolsinsap, Thailand President of Hepatology Society of the Philippines Panelist: Case presenters: |
12.00-13.30 | Lunch Symposium III LF Asia (Thailand) Ltd. “Medical Management of Hepatitis C” Moderator: Tawesak Tanwandee Speaker: K.Rajender Reddy |
13.30-15.00 | Symposium V Revisiting HCC Moderators: Wattana Sukeepaisarnjaroen, Thailand Khin Maung Win, Myanmar |
13.30-13.50 | 1.The 2016 evidence for preventing HCC and HCC recurrence Rosmawati Mohamed, Malaysia |
13.50-14.10 | 2.Innovations in surveillance and diagnosis of very early HCCs Linda Brown, Thailand |
14.10-14.30 | 3.Early HCC: resect, ablate or transplant? Grace Wong, Hong Kong |
14.30-14.50 | 4.New paradigms in the management of intermediate HCC Rino Alvani Gani, Indonesia |
14.50-15.00 | Discussion |
15.00-15.30 | Coffee break |
15.30-16.00 | Keynote lecture II: Occult HBV Infection Moderators: Pongphob Intaraprasong, Thailand Speaker: |
16.00-16.30 | Keynote lecture III: New Therapies for HBV Moderators: Abhasnee Sobhonslidsuk, Thailand Teerha Piratvisuth, Thailand Speaker: |
16.30-17.20 | NAFLD: problems beyond the liver Moderators: Leon Adams, Australia Supatsri Sethasine, Thailand |
16.30-16.50 | 1.Asian Perspectives Sombat Treeprasertsuk, Thailand |
16.50-17.10 | 2.Italian Perspectives Ferruccio Bonino, Italy |
17.10-17.20 | Discussion |
17.20-17.40 | New paradigm in the management of hepatic encephalopathy
Moderator: Speaker: |
17.40-18.00 | THASL Annual meeting 2016 |
23rd January 2016
Theme: New paradigms in the management of liver diseases
Saturday, 23rd January 2016 | |
8.30-10.00 | Symposium VI Pearls in the management of cirrhotic patients: Moderators: M.L. Taya Kitiyakara, Thailand President of Hepatology Society of the Philippines |
8.30-8.55 | 1.Current concepts in the management of difficult ascites Siwaporn Chainuvati, Thailand |
8.55-9.20 | 2.Infection in cirrhosis Chalermrat Bunchorntavakul, Thailand |
9.20-9.45 | 3.Friend or foe ?: PPIs and beta-blockers in cirrhotic patients Grace Wong, Hong Kong |
9.45-10.00 | Discussion |
10.00-10.30 | Coffee break |
10.30-11.00 | State of the art lecture: Acute on chronic liver failure Moderators: Watcharasak Chotiyaputta,Thailand Rino Alvani Gani, Indonesia Speaker: |
11.00-11.50 | Plenary III Update in management of NASH Moderators: Sombat Treeprasertsuk, Thailand Rino Alvani Gani, Indonesia |
11.00-11.20 | 1.The management of lean NASH: No weight and no time to lose? Jacob George, Australia |
11.20-11.40 | 2.Refractory NASH: What can we do? Diana Alcantara-Payawal, Philippines |
11.40-11.50 | Discussion |
12.00-13.30 | Lunch |
13.30-15.00 | Highlights in Hepatology Moderators: Tawesak Tanwandee,Thailand Wattana Sukeepaisarnjaroen, Thailand |
13.30-14.00 | 1.Viral hepatitis Pisit Tangkijvanich, Thailand |
14.00-14.30 | 2.Non-viral liver diseases Ray Kim, USA |
14.30-15.00 | 3.Cirrhosis and liver transplantation Piyawat Komolmit, Thailand |
15.00-15.20 | Closing Ceremony |